|
|
Anavex comments on new Alzheimer's disease diagnostic guidelines
Sources News Release
http://www.sources.com/Releases/NR1279.htm
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot
Date Written: 17/05/2011
Year Published: 2011
Resource Type: Article
Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer’s disease published recently by the National Institute on Aging (NIA) and the Alzheimer’s Association, which have been updated
Abstract: Hoboken, NJ – May 17, 2011 -- Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer’s disease published recently by the National Institute on Aging (NIA) and the Alzheimer’s Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer’s di...
To read the full release go to http://www.sources.com/Releases/NR1279.htm
Topics
|
AlterLinks
c/o Sources
© 2023.
|
|
|
|
